ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 31301 | Rec_0031399 | FLAK50I |
FAKLLALALKLKL |
synthetic construct [Synthetic] |
Anticancer, Cytotoxic |
SW-480 |
- | MTT/MTS assay |
- | US6875744B2 |
NO |
| 31302 | Rec_0031400 | Unnamed |
VRLIKFLYQ |
synthetic construct [Synthetic] |
Antimicrobial |
- |
- | - |
- | US 2006/0089488 A1 |
YES |
| 31303 | Rec_0031401 | Unnamed |
LNVPGEIVE |
Bos taurus [Animal] |
Antihypertensive |
- |
- | - |
23194537 | - |
NO |
| 31304 | Rec_0031402 | Lactocin 705beta (lac705beta; chain b of Lactocin 705; Bacteriocin) |
GFWGGLGYIAGRVGAAYGHAQASANNHHSPING |
Lactobacillus casei [Bacterium] |
Antimicrobial, Antibacterial |
- |
- | - |
10754241 | - |
NO |
| 31305 | Rec_0031403 | LL-37(1-4,17-27) |
LLGDFKRIVQRIKDF |
Homo sapiens [Animal] |
Antibacterial |
KBv |
- | MTT/MTS assay |
16637646 | - |
YES |
| 31306 | Rec_0031404 | Peptide chain C in PDB 4PXM |
ILHRLL |
not reported [other] |
Protein-binding, Peptide-protein interaction, Structural binding |
PDB 4PXM receptor chain A |
- | Protein-peptide complex structure |
- | - |
YES |
| 31307 | Rec_0031405 | P3(derived from HCV polyprotein) |
DDSVVCAAMSYSHA |
synthetic construct [Synthetic] |
Antimicrobial, Antiviral |
- |
- | - |
14694985 | - |
NO |
| 31308 | Rec_0031406 | Lysozyme (EC 3.2.1.17) |
MDDFLPELVEDLRRDEGFRSKPYHCPAGKLTIGYGRNIEDNGITEREARVLLGNDAVAAIQELRQHLGWFDGLSPARKRALANMAFNLGWPRLSGFRNMLAAMAEGDFGRAATEAENSAWFRQVGDRARRIVAMIREG |
Magnetospirillum sp. UT-4 [Bacterium] |
Antimicrobial, Bacteriolytic enzyme, Hydrolase, Glycosidase, Non-hemolytic, Non-ribosomal |
- |
- | - |
- | - |
NO |
| 31309 | Rec_0031407 | D-LAK160 |
KKLAKLALLKWLLALKLLALKALKK |
synthetic construct [Synthetic] |
Antimicrobial,Antibacterial,Anti-Gram-negative |
Pseudomonas aeruginosa |
6.23±0.71 μM | MIC |
22869378 | - |
YES |
| 31310 | Rec_0031408 | Unnamed |
RKAGAIGAG |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
- |
- | - |
- | US 2008/0207522 A1 |
NO |
| 31311 | Rec_0031409 | Peptide 171 |
RPDKPRPYSPSPRPPRPVR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram-positive, Anti-Gram-negative |
Escherichia coli BW25113 |
128 μg/mL | MIC |
35223768 | - |
YES |
| 31312 | Rec_0031410 | 22-39 |
VKFPGGGQIVGGVYLLPR |
Hepatitis C virus [Virus] |
Antiviral, Assembly inhibitor |
Hepatitis C virus (Assembly) |
- | EMSA |
22452666 | - |
YES |
| 31313 | Rec_0031411 | Unnamed |
SKPHT |
not reported [other] |
Antihypertensive |
- |
- | - |
25392419 | - |
NO |
| 31314 | Rec_0031412 | Unnamed |
IGKGG |
not reported [other] |
Antihypertensive,ACE inhibitory |
ACE |
10 μM | IC50 |
- | - |
NO |
| 31315 | Rec_0031413 | Dermaseptin-6 (DStar 06; Frogs, amphibians, animals) |
ALWKNMLKGIGKLAGQAALGAVKTLVGA |
Phyllomedusa tarsius [Animal] |
Antimicrobial, Antibacterial, Anti-Gram-positive |
Gram-neagtive bacterium: Pseudomonas aeruginosa |
- | - |
- | - |
NO |
| 31316 | Rec_0031414 | Unnamed |
KXWKEXK |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028 |
100 μg/mL | MIC |
28547390 | - |
YES |
| 31317 | Rec_0031415 | Mastoparan-VT3 |
INLKAITALAKKLL |
Vespa tropica [Animal] |
Antimicrobial, Antibacterial, Antifungal |
Enterococcus faecalis ATCC 29212 |
5 μg/mL | MIC |
24012601 | - |
YES |
| 31318 | Rec_0031416 | rCRAMP |
GLLRKGGEKIGEKLKKIGQKIKNFFQKLGPQPEQ |
Mus caroli [Animal] |
Antimicrobial, Antibacterial |
Escherichia coli TOP10 |
4.02 OD_ID (dimensionless) | Mex pooled growth assay (OD_ID at 4.5 h) |
35260685 | - |
YES |
| 31319 | Rec_0031417 | Peptide chain B in PDB 3TOD |
LEACAF |
not reported [other] |
Protein-binding, Peptide-protein interaction, Structural binding |
PDB 3TOD receptor chain A |
- | Protein-peptide complex structure |
- | - |
YES |
| 31320 | Rec_0031418 | CNP-29 |
YKGGNKKGLSKGCFGLKLDRIGSMSGLGC |
Mus musculus [Animal] |
Hormone, Cardiovascular |
- |
- | - |
- | - |
NO |